Form 4: Director Barbara Bodem Increases Stake in Enovis Corp

Director Barbara W. Bodem acquired 9,346 shares of Enovis Corp common stock as part of a compensation-related grant.

Summary

• Director Barbara W. Bodem acquired 9,346 shares of Enovis Corp (ENOV) common stock on May 19, 2026.
• The shares were acquired at a price of $0.00, indicating an equity grant rather than a market purchase.
• Following this transaction, the director's total beneficial ownership in the company increased to 24,201 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it represents standard director compensation that increases insider alignment without indicating a change in company strategy.

Positives

• Increased alignment between the director and shareholders through higher equity ownership.
• The acquisition reflects confidence in the company's long-term prospects.

Negatives

• None identified in this filing.

Risks

• None identified in this filing.

Future Outlook

No specific forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to align board member interests with shareholder value creation in the medical technology sector.

Comparison to Industry Standards

• The transaction is consistent with standard director compensation packages for mid-cap medical device companies.
• The acquisition of equity by board members is viewed as a positive signal of corporate stability.

Stakeholder Impact

• Shareholders may view the increased director stake as a positive sign of commitment to the company's long-term performance.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Enovis, ENOV, Insider Trading, Form 4, Director Ownership, Equity Grant